In the 1980s, MOG was identified as a target in experimental autoimmune encephalomyelitis (3, 4), however, early ELISA assays showed that MOG antibodies were widely present in both healthy individuals and multiple sclerosis patients, lacking specificity (5, 6). This evidence concerns the gene MOG and experimental autoimmune encephalomyelitis.